These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28437390)

  • 1. Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Singh N; Dies D; Samant H
    Transplantation; 2017 May; 101(5):e192. PubMed ID: 28437390
    [No Abstract]   [Full Text] [Related]  

  • 2. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs).
    La Manna G
    J Nephrol; 2018 Apr; 31(2):185-187. PubMed ID: 29411309
    [No Abstract]   [Full Text] [Related]  

  • 3. Management and treatment of the HCV-infected kidney transplant patient.
    Wong T; Bloom RD
    Semin Dial; 2019 Mar; 32(2):169-178. PubMed ID: 30536995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C in potential kidney and heart transplant patients.
    Fabrizi F; Bunnapradist S; Martin P
    Clin Liver Dis; 2005 Aug; 9(3):487-503, viii. PubMed ID: 16023979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha 2a.
    Sperl J; Petrasek J; Spicak J; Viklicky O
    J Hepatol; 2008 Sep; 49(3):461-2; author reply 462-3. PubMed ID: 18644649
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Goldfarb DA
    J Urol; 2020 Dec; 204(6):1369. PubMed ID: 32955983
    [No Abstract]   [Full Text] [Related]  

  • 8. HCV Antiviral Therapy in Liver Transplant Candidates and Recipients With Renal Insufficiency.
    Verna EC; Brown RS
    Transplantation; 2017 May; 101(5):924-932. PubMed ID: 28212220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era.
    Schaubel DE; Tran AH; Abt PL; Potluri VS; Goldberg DS; Reese PP
    JAMA; 2022 Sep; 328(11):1102-1104. PubMed ID: 35994263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
    Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Hepatitis C Antibodies Without Viral Transmission in Hepatitis C-Negative Recipients Receiving Kidneys From Hepatitis C-Positive Donors Treated With Direct-Acting Antiviral Therapy.
    Agarwal N; Davis RJ; Gracey DM; Wong G; Kable K; Wong JKW; Nankivell BJ; Strasser S; Wyburn K
    Transplantation; 2018 Mar; 102(3):e121-e122. PubMed ID: 29166337
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Transplants for Patients With Hepatitis C Virus Infection.
    Ann Intern Med; 2018 Aug; 169(4):. PubMed ID: 29987320
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary tuberculosis in an HIV- and hepatitis C virus-coinfected kidney-pancreas transplant recipient: a case report.
    Dalla Gasperina D; Tozzi M; Astuti N; Balsamo ML; Donati D; Rossi A; Dionigi R; Grossi PA
    Transplant Proc; 2011 May; 43(4):1206-9. PubMed ID: 21620090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.
    Bonacci M; Londoño MC; Esforzado N; Forns X; Sotoca JM; Campistol JM
    Transpl Int; 2015 Nov; 28(11):1345-9. PubMed ID: 26073850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates.
    Campbell MS; Constantinescu S; Furth EE; Reddy KR; Bloom RD
    Dig Dis Sci; 2007 Oct; 52(10):2501-7. PubMed ID: 17394069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral hepatitis in hemodialysis and renal transplantation patients].
    Pol S; Legendre C
    Nephrologie; 1994; 15(3):191-5. PubMed ID: 7969710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
    Fernández I; Meneu JC; Colina F; García I; Muñoz R; Castellano G; Fuertes A; Abradelo M; Lumbreras C; Moreno E; Solís-Herruzo JA
    Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.